Workflow
XZB(603040)
icon
Search documents
新坐标(603040) - 新坐标2024年度社会责任报告
2025-04-28 10:13
2024 年度社会责任报告 公司代码:603040 公司简称:新坐标 杭州新坐标科技股份有限公司 2024 年度社会责任报告 二〇二五年四月 | 七.社会责任展望 22 | | --- | 2024 年度社会责任报告 关于本报告 本公司董事会及全体董事保证本报告内容不存在任何虚假记载、误导性 陈述或重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责 任。 报告时间范围 本报告为年度报告,时间跨度为 2024 年 1 月 1 日至 2024 年 12 月 31 日。部 分表述及数据适当超出上述期间范围。 报告组织范围 杭州新坐标科技股份有限公司及其下属子公司。 代指说明 为便于表述,报告中"杭州新坐标科技股份有限公司"简称为"新坐标"、"公 司"。 报告数据说明 本报告中采用的数据与相关内容主要通过公司及下属分、子公司内部收集统 计,如与公司年报有出入,以年报为准。 报告编制依据 本报告根据《上海证券交易所上市公司自律监管指引第 1 号——规范运作》 中关于社会责任的相关要求,结合公司履行社会责任的具体情况进行编制。 2024 年度社会责任报告 一. 关于新坐标 (一) 公司介绍 杭州新坐标科技股份有 ...
新坐标(603040) - 新坐标关于变更注册资本并相应修订《公司章程》的公告
2025-04-28 10:13
关于变更注册资本并相应修订《公司章程》的公告 本事项尚需提交股东大会审议,待股东大会审议通过后授权公司董事长及其 授权人士办理本次相关工商变更登记及章程备案,《公司章程》的修订最终以市 场监督管理部门最终登记备案为准。授权的有效期限为自股东大会审议通过后起 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 杭州新坐标科技股份有限公司(以下简称"公司")于 2025 年 4 月 25 日召 开了第五届董事会第十二次会议,审议通过了《关于变更注册资本并相应修订< 公司章程>的议案》,同意公司减少注册资本,并对《公司章程》进行修订。具体 情况如下: 鉴于公司 2024 年度限制性股票激励计划(以下简称"本激励计划")的激励 对象唐兰军、邹健已离职,已不具备本激励计划激励资格,董事会将对以上 2 名激励对象所持有的已获授但尚未解锁的 31,000 股限制性股票进行回购注销。 公司总股本 136,517,896 股将减少至 136,486,896 股,公司注册资本由原来的 136,517,896 元变更为 136,486,896 元,故需 ...
新坐标(603040) - 新坐标2024年内部控制评价报告
2025-04-28 10:13
公司代码:603040 公司简称:新坐标 杭州新坐标科技股份有限公司 2024年度内部控制评价报告 杭州新坐标科技股份有限公司全体股东: 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求(以下简称企业内部 控制规范体系),结合本公司(以下简称公司)内部控制制度和评价办法,在内部控制日常监督和专项 监督的基础上,我们对公司2024年12月31日(内部控制评价报告基准日)的内部控制有效性进行了评价。 √有效 □无效 根据公司财务报告内部控制重大缺陷的认定情况,于内部控制评价报告基准日,不存在财务报告内 部控制重大缺陷,董事会认为,公司已按照企业内部控制规范体系和相关规定的要求在所有重大方面保 持了有效的财务报告内部控制。 3. 是否发现非财务报告内部控制重大缺陷 □是 √否 一. 重要声明 按照企业内部控制规范体系的规定,建立健全和有效实施内部控制,评价其有效性,并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏 ...
新坐标(603040) - 新坐标董事会关于独立董事独立性情况的专项意见
2025-04-28 10:13
经核查独立董事王刚、陈军、戴国骏的任职经历以及签署的相关自查文件, 上述人员未在公司担任除独立董事以外的任何职务,也未在公司主要股东公司担 任任何职务,与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独 立客观判断的关系,因此,公司独立董事符合《上市公司独立董事管理办法》、 《上海证券交易所上市公司自律监管指引第 1 号——规范运作》中对独立董事独 立性的相关要求。 杭州新坐标科技股份有限公司董事会 2025 年 4 月 25 日 杭州新坐标科技股份有限公司 董事会关于独立董事独立性情况的专项意见 根据证监会《上市公司独立董事管理办法》、上海证券交易所《股票上市规 则》《上市公司自律监管指引第 1 号——规范运作》等要求,公司董事会就公司 在任独立董事王刚、陈军、戴国骏的独立性情况进行评估并出具如下专项意见: ...
新坐标:拟7700万元设立杭州九月八精密传动科技有限公司
news flash· 2025-04-28 09:44
Core Viewpoint - The company plans to establish a new subsidiary, Hangzhou September Eight Precision Transmission Technology Co., Ltd., with a total investment of approximately 50 million RMB, aimed at enhancing its competitive edge and optimizing its business structure [1]. Group 1 - The company will invest 77 million RMB to hold a 77% stake in the new subsidiary [1]. - The registered capital of the new subsidiary is set at 100 million RMB [1]. - The remaining funds for the project will be sourced from additional investments by shareholders or through self-raised funds by the joint venture [1]. Group 2 - The new subsidiary will focus on the research, production, and sales of precision transmission components such as rolling ball screws and rolling lead screws [1]. - Establishing the joint venture aligns with the company's business and strategic planning [1]. - The initiative is expected to enhance the company's overall competitiveness [1].
大辰教育2025职场新机遇人才成长峰会 | 成都站圆满落幕,解码AI时代职业新坐标
Jin Tou Wang· 2025-04-27 04:45
Core Insights - The summit focused on new career opportunities and transformation paths in the context of AI, low-altitude economy, and green energy, emphasizing the importance of aligning personal growth with industry trends [1][22] Group 1: Regional Industry Advantages - Chengdu has established a differentiated advantage in sectors like chip design (annual scale exceeding 30 billion), AI algorithms (25% of high-paying positions), and medical technology (AI imaging penetration rate of 35%), positioning itself as a hub for technological innovation in Western China [5] - Leading companies in Chengdu's chip sector, such as Huawei HiSilicon and Zhenxin Technology, offer annual salaries ranging from 350,000 to 1.2 million [5] Group 2: Salary Structure Insights - In comparison to Beijing's "olive-shaped" salary distribution, Chengdu exhibits a "pyramid-shaped" structure where 70% of workers are in entry-level positions (8,000-15,000), while only 12% occupy high-paying roles, indicating a need for career advancement through industry positioning and skill enhancement [5] Group 3: Wealth Accumulation Pathways - The summit introduced a five-stage wealth accumulation theory, highlighting the significance of the "golden career period" (ages 29-35) and advocating for diversified asset allocation in high-growth industries, citing examples like Shenzhen's housing prices increasing tenfold in eight years and Huawei's stock compounding growth [5] Group 4: AI and Career Development - The discussion on AI's impact on career paths outlined three stages of AI technology penetration: infrastructure layer (e.g., OpenAI), application tools layer (e.g., Manus AI), and industry transformation layer (e.g., AI-driven supply chain optimization in Chengdu's tea industry) [9][10] - Strategies for career transition included deepening industry chain engagement, empowering traditional industries with AI, and the rise of "super individuals" leveraging AI for creative endeavors [12] Group 5: Enhancing Workplace Competitiveness - The "constant-variable" career evolution model was proposed, emphasizing the identification of personal strengths through assessments and the need for career choices to align with individual values [14] - The summit highlighted that AI serves as an amplifier rather than a replacement, urging professionals to focus on unique human skills that AI cannot replicate, such as empathy and critical thinking [16] Group 6: AI in Job Seeking - Practical applications of AI in job seeking were discussed, including building a career knowledge base, optimizing resumes using AI tools, and managing professional image through social media [18][20] - The summit concluded with a call for individuals to integrate their strengths with market demands to achieve exponential career growth, positioning 2025 as a new starting point rather than an endpoint [22]
中国万亿零担整合潮起,谁能成为资本洼地新坐标?
智通财经网· 2025-04-22 00:57
Core Viewpoint - The Chinese less-than-truckload (LTL) logistics market is entering a phase of differentiation, with a projected market size of 1.7 trillion yuan in 2024 and a compound annual growth rate of 2.1% over the next five years, indicating significant growth potential [1] Market Overview - The market for LTL logistics in China is expected to continue releasing substantial capacity, with full-network express companies increasing their penetration from 11% in 2019 to 16% in 2024, while leading companies have surpassed 60% market share [1] - Compared to the U.S. LTL industry, which completed initial consolidation in 2010, China's LTL market is still in the early stages of integration, with leading players like Aneng Logistics gaining market share [1][2] Company Performance - Aneng Logistics is projected to achieve revenue of 11.576 billion yuan in 2024, a year-on-year increase of 16.7%, with adjusted net profit soaring by 64.2% to 837 million yuan [1] - In contrast, Debon Logistics is expected to report revenue of 40.379 billion yuan, an increase of 11.3%, and net profit of 861 million yuan, up 15.41% [5] Valuation Insights - As of April 16, Debon's price-to-earnings (PE) ratio is 18 times, while Aneng's is 11.9 times, indicating a significant market perception gap [7] - Institutional investors have set target prices for Aneng at 11 to 12 Hong Kong dollars, reflecting a belief in its growth potential and undervaluation [7] Competitive Landscape - Aneng and Debon operate in the same logistics sector but have different market focuses, with Aneng covering a broader range of express services [2] - The difference in business models (franchise vs. direct operation) affects their cost control and profitability, with Aneng showing a net profit margin of 7.1% in 2023, compared to Debon's declining margin around 2% [3][5] Growth Potential - Aneng's strategic initiatives, including network optimization and cost control, are expected to sustain its high growth trajectory, with projected revenue growth of 10% to 15% in 2025 and adjusted net profit growth of no less than 20% [11] - The company has demonstrated strong cash flow, with net cash flow from operating activities reaching 2.131 billion yuan in 2024, a 24.9% increase, providing a solid foundation for shareholder returns [12] Industry Dynamics - The rapid expansion of e-commerce logistics in China continues to drive growth in the LTL market, with leading companies like Aneng building competitive advantages through scale and cost leadership [13] - The ongoing industry consolidation presents structural opportunities for top players to enhance their market positions and profitability [13]
新坐标:已回购35.68万股 使用资金总额874.39万元
news flash· 2025-04-16 08:23
新坐标(603040)公告,公司于2025年4月16日首次通过集中竞价交易方式回购股份,回购35.68万股, 占公司总股本的0.2614%,回购价格区间为23.89元/股至24.7元/股,已支付的总金额为874.39万元(不含 交易费用)。本次回购符合相关法律法规及公司回购股份方案的要求,回购股份将用于实施员工持股计 划或股权激励。 ...
“每个康复的患者,都是中非友谊的新坐标”(海外纪闻)
Core Insights - The Chinese medical team has successfully treated numerous patients in Niger, showcasing the effectiveness of their medical interventions and the collaboration between Chinese and Nigerien doctors [1][2][3] Group 1: Medical Achievements - A 5.5-year-old boy named Hama underwent successful treatment for a severe leg injury that local doctors deemed required amputation, thanks to the introduction of bone transport technology by the Chinese medical team [1] - The Chinese medical team has performed over 9 surgeries on Hama, ultimately achieving good healing results, allowing him to walk again [1] - The Chinese medical team has provided high-quality medical services to nearly one million patients since 1976, demonstrating a long-term commitment to healthcare in Niger [3] Group 2: Hospital Infrastructure - The Niger Comprehensive Demonstration Hospital, built with Chinese aid, spans 16 hectares and has a total construction area of 33,000 square meters, making it one of the largest hospitals in Niger and West Africa [3] - The hospital features multiple departments, including trauma orthopedics, cardiovascular medicine, and traditional Chinese medicine, equipped with modern surgical facilities [1][3] Group 3: Traditional Chinese Medicine - The Traditional Chinese Medicine Center has treated over 3,000 patients since its establishment in May 2023, offering services such as acupuncture, cupping, and herbal medicine [2] - A patient named Sedi reported significant improvement from facial paralysis after receiving acupuncture treatment at the center [2]
新坐标(603040) - 新坐标关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告
2025-04-11 07:45
根据《上市公司股份回购规则》、《上海证券交易所上市公司自律监管指引 第 7 号——回购股份》的相关规定,现将董事会公告回购股份决议的前一个交易 日(即 2025 年 4 月 9 日)登记在册的前十大股东和前十大无限售条件股东的名 称及持股数量、比例情况公告如下: | 序号 | 股东名称 | 持股数(股) | 占总股本的 比例(%) | | --- | --- | --- | --- | | 1 | 杭州佐丰投资管理有限公司 | 69,205,500 | 50.69 | | 2 | 胡欣 | 3,220,000 | 2.36 | | 3 | 姚国兴 | 1,470,175 | 1.08 | | 4 | 浙江宁聚投资管理有限公司-宁聚量化稳 | 1,299,970 | 0.95 | | | 盈 6 期私募证券投资基金 | | | | 5 | 北京嘉华宝通咨询有限公司 | 1,244,369 | 0.91 | | 6 | 杭州新坐标科技股份有限公司-2024 年员 | 1,126,000 | 0.82 | | | 工持股计划 | | | | 7 | 华润深国投信托有限公司-重阳 3 期证券 | 1,017,448 ...